Literature DB >> 7967474

Vitamin-responsive complex I deficiency in a myopathic patient with increased activity of the terminal respiratory chain and lactic acidosis.

H D Bakker1, H R Scholte, J A Jeneson, H F Busch, N G Abeling, A H van Gennip.   

Abstract

An 11-year-old girl with exercise intolerance, fatiguability from early childhood, had high blood lactate levels. Histochemistry showed increased activity of succinate dehydrogenase at the periphery of the muscle fibres, whereas aggregates of mitochondria were seen by electron microscopy. Biochemical investigation of isolated mitochondria and homogenate from muscle showed evidence of a severe complex I deficiency. In contrast, succinate dehydrogenase, complex II+III and complex IV were increased in activity. Therapy with biotin, riboflavin, nicotinamide, carnitine and amino acids resulted in an improvement of her endurance. 31P NMR spectroscopy of her forearm muscle showed a decreased ratio of phosphocreatine (PCr) over ATP. After exercise the PCr recovery rate was 26% of the average rate in 20 healthy untrained controls. When the therapy was suspended the PCr/ATP ratio at rest decreased from 2.60 to 2.34, and the PCr recovery rate after exercise decreased to 21% of the average control rate. The therapy was reinstituted but only riboflavin and carnitine were given. The PCr/ATP ratio increased to 2.60 and the PCr recovery rate increased to 32% of the control rate. Improvement of the energy metabolism in patients with defects in the oxidative phosphorylation may add to the quality of life; 31P NMR spectroscopy can measure these improvements.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7967474     DOI: 10.1007/BF00711617

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  20 in total

1.  31P-NMR study of skeletal muscle metabolism in patients with chronic respiratory impairment.

Authors:  T Kutsuzawa; S Shioya; D Kurita; M Haida; Y Ohta; H Yamabayashi
Journal:  Am Rev Respir Dis       Date:  1992-10

2.  Cytochrome c oxidase deficiency in subacute necrotizing encephalomyelopathy.

Authors:  W F Arts; H R Scholte; M C Loonen; H Przyrembel; J Fernandes; J M Trijbels; I E Luyt-Houwen
Journal:  J Neurol Sci       Date:  1987-01       Impact factor: 3.181

3.  Carnitine deficiency, mitochondrial dysfunction and the heart. Identical defect of oxidative phosphorylation in muscle mitochondria in cardiomyopathy due to carnitine loss and in Duchenne muscular dystrophy.

Authors:  H R Scholte; R Rodrigues Pereira; H F Busch; F G Jennekens; I E Luyt-Houwen; M H Vaandrager-Verduin
Journal:  Wien Klin Wochenschr       Date:  1989-01-06       Impact factor: 1.704

4.  Gas chromatography of urinary N-phenylacetylglutamine.

Authors:  J P Kamerling; M Brouwer; D Ketting; S K Wadman
Journal:  J Chromatogr       Date:  1979-10-11

5.  Deficiency of the adenine nucleotide translocator in muscle of a patient with myopathy and lactic acidosis: a new mitochondrial defect.

Authors:  H D Bakker; H R Scholte; C Van den Bogert; W Ruitenbeek; J A Jeneson; R J Wanders; N G Abeling; B Dorland; R C Sengers; A H Van Gennip
Journal:  Pediatr Res       Date:  1993-04       Impact factor: 3.756

6.  Bioenergetics of intact human muscle. A 31P nuclear magnetic resonance study.

Authors:  D J Taylor; P J Bore; P Styles; D G Gadian; G K Radda
Journal:  Mol Biol Med       Date:  1983-07

7.  Mitochondrial myopathy with partial cytochrome oxidase deficiency and impaired oxidation of NADH-linked substrates.

Authors:  H S Sherratt; N E Cartlidge; M A Johnson; D M Turnbull
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

8.  Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.

Authors:  D M Mancini; G Walter; N Reichek; R Lenkinski; K K McCully; J L Mullen; J R Wilson
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

9.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

10.  A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity.

Authors:  J A Morgan-Hughes; P Darveniza; D N Landon; J M Land; J B Clark
Journal:  J Neurol Sci       Date:  1979-09       Impact factor: 3.181

View more
  4 in total

Review 1.  The treatment of congenital lactic acidoses.

Authors:  A A Morris; J V Leonard
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases.

Authors:  J Panetta; L J Smith; A Boneh
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 3.  Disorders of mitochondrial long-chain fatty acid oxidation.

Authors:  R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 4.  Pulmonary hypertension as a manifestation of mitochondrial disease: A case report and review of the literature.

Authors:  Shan Xu; Xiaoling Xu; Jisong Zhang; Kejing Ying; Yuquan Shao; Ruifeng Zhang
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.